Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

Market Update

Julia Lee
June 21, 2018

Equity Investor 18 June

Julia Lee
June 19, 2018

Market Update

Julia Lee
June 7, 2018

Market Update

Julia Lee
June 6, 2018

Equity Investor

Julia Lee
June 5, 2018

Equity Investor 28 May

Julia Lee
May 29, 2018

The SMSF trust deed – video

Bell Direct
May 28, 2018

Setting up your SMSF – video

Bell Direct
May 28, 2018

Equity Investor 21 May

Julia Lee
May 22, 2018